Q32 Bio (QTTB) Divestments (2022)
Q32 Bio's (QTTB) quarterly Divestments came in at $130.0 million in Q1 2022.
Q32 Bio (QTTB) Divestments (2022) Analysis & Trends
Q32 Bio's Divestments history runs 1 years deep, the most recent figure standing at $130.0 million for Q1 2022.
- On a quarterly basis, Divestments changed N/A year-over-year to $130.0 million in Q1 2022; TTM through Dec 2022 was $130.0 million, a N/A change from a year earlier, with the FY2022 full-year figure at $130.0 million, changed N/A from the prior year.
- Divestments steadied at $130.0 million in Q1 2022 per QTTB's latest filing.
- Across five years, Divestments topped out at $130.0 million in Q1 2022 and bottomed at $130.0 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 130.00 Mn |